DIVPENIA
LIVE

Serial Number

79105623

Owner

IMMUNID

Attorney

Dianne M. Smith-Misemer

Filing Date

Aug 31, 2011

Add to watchlist:

No watchlists yet
View on USPTO

DIVPENIA Trademark

Serial Number: 79105623 • Registration: 4239791

DIVPENIA is a trademark filed by IMMUNID on August 31, 2011. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

IMMUNID (3 trademarks)

7 Parvis Louis Néel Minatec

Entity Type: 99

Trademark Details

Filing Date

August 31, 2011

Registration Date

November 13, 2012

Published for Opposition

August 28, 2012

Cancellation Date

August 31, 2021

Goods & Services

Pharmaceutical preparations for in-vitro diagnosis and for identifying and characterizing immune dysfunction, tracking the progress of disease and measuring the effectiveness of immunotherapy, and veterinary preparations for in-vitro diagnosis and for identifying and characterizing immune dysfunction, tracking the progress of disease and measuring the effectiveness of immunotherapy; sanitary preparations for medical use; food products nutritionally enriched adapted for medical use; food for babies; chemical preparations for sanitation; medicinal herbs and food products with probiotic or prebiotic effects adapted for medical use

Chemicals for scientific and research purposes, namely, solvents, reagents, enzymes, proteins, nucleic acids, microbiological carriers, cell culture media, carriers for conserving DNA and carriers for conserving biological samples used in industry, science, biological research, and diagnosis

Medical services; veterinary services; medical assistance; hospital services for in-vitro diagnosis and for identifying and characterizing immune dysfunction, tracking the progress of disease and measuring the effectiveness of immunotherapy

Surgical, medical and veterinary apparatus and instruments for in-vitro diagnosis of immune dysfunction and for identifying and characterizing immune dysfunction, tracking the progress of disease and measuring the effectiveness of immunotherapy; surgical, medical and veterinary apparatus and instruments incorporating data management software, namely, medical imaging apparatus, automated Polymerase Chain Reaction workflow apparatus for medical molecular diagnostic and immunochemical testing apparatus for medical use, allowing the characterization of a physiological and/or clinical state, to rate its clinical risk and/or prescribe an adequate medical treatment for in-vitro diagnosis and for identifying and characterizing immune dysfunction, tracking the progress of disease and measuring the effectiveness of immunotherapy

Scientific research; provision of databases for online consultation in the field of scientific research relating to immunology and in vitro diagnosis for scientific research; technological consulting and research relating to immunology and in-vitro diagnosis; computer software and hardware design and development for others; product research and development for others; technical project studies, namely, conducting feasibility studies; engineers' services, namely, planning technical projects and designing lines for treating web products; consulting in the field of computer programming; software consultancy; scientific research for medical purposes

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Mar 26, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Mar 26, 2022 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Jun 5, 2020 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
May 11, 2020 INTS
INVALIDATION PROCESSED
May 11, 2020 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 14, 2020 INTR
CANCELLED SECTION 71
Jun 14, 2019 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 13, 2017 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 10, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 14, 2013 FICS
FINAL DISPOSITION PROCESSED
Feb 14, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 13, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 13, 2012 R.PR
NOTIFICATION PROCESSED BY IB
Sep 30, 2012 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 28, 2012 NPUB
PUBLISHED FOR OPPOSITION
Aug 28, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 8, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 8, 2012 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 8, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 23, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 20, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2012 CRFA
ASSIGNED TO LIE
Jul 3, 2012 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 18, 2012 TROA
REFUSAL PROCESSED BY IB
Jan 9, 2012 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 21, 2011 RFCS
REFUSAL PROCESSED BY MPU
Dec 21, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 20, 2011 RFCR
NON-FINAL ACTION WRITTEN
Dec 19, 2011 CNRT
ASSIGNED TO EXAMINER
Dec 19, 2011 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 13, 2011 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 9, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 8, 2011 REPR